Resources

This channel contains a range of downloadable resources relating to Cancer-associated thrombosis (CAT) that are available free to registered users. These include PDFs as well as Word and Excel documents. This channel can be sorted chronologically, by file name or file type by choosing the relevant option from the drop-down list below. This channel will be updated on an ongoing basis.

Resources
International Guidelines
  • external-resource-1

    Current Perspectives on Preventing VTE in Patients With Cancer

    Nov 21, 2016 - external resource

    Provided by PeerVoice through an unrestricted educational grant from LEO Pharma. PeerVoice and the faculty presenters had editorial independence in the preparation of this activity.

    Access External Resource
  • CANCER-ASSOCIATED THROMBOSIS (CAT), A NEGLECTED CAUSE OF CANCER DEATH: ACTIONS NEEDED TO INCREASE HEALTH OUTCOMES AND REDUCE MORTALITY

    CANCER-ASSOCIATED THROMBOSIS (CAT), A NEGLECTED CAUSE OF CANCER DEATH: ACTIONS NEEDED TO INCREASE HEALTH OUTCOMES AND REDUCE MORTALITY

    Oct 28, 2016 - Pdf

    Report summarising the findings of an Expert Steering Group meeting in Belgium

    LEO Pharma, Denmark, has provided financial support, in the form of consultancy and secretarial services, for this report and the meeting that preceded it. The organisation of the meeting was carried out independently of this support and the company has not influenced the discussions and conclusions, which reflect, exclusively, the views of the expert participants. LEO Pharma, Denmark has reviewed this report for factual accuracy only.

    Preview Download Resource
  • ALL-PARTY PARLIAMENTARY THROMBOSIS GROUP (APPTG) REPORT, OCTOBER 2016

    ALL-PARTY PARLIAMENTARY THROMBOSIS GROUP (APPTG) REPORT, OCTOBER 2016

    Oct 27, 2016 - Pdf

    Preview Download Resource
  • BCCY video

    Blood Clots, Cancer and You Alert Pocket Card

    The objective of this educational video and pocket card is to enable people living with cancer to become clot-aware and to recognise signs and symptoms of CAT.

    Sep 29, 2016 - video (filesize: 50MB), - pdf

    Watch Video Download Video Preview Card Download Card
  • All-Party Parliamentary Thrombosis Group (APPTG) Report

    All-Party Parliamentary Thrombosis Group (APPTG) Report

    Mar 7, 2016 - Pdf

    Preview Download Resource
  • Masterclass on Cancer & Thrombosis – Meeting report, Trinity Centre for Health Sciences
Feb 6, 2015

    Masterclass on Cancer & Thrombosis – Meeting report, Trinity Centre for Health Sciences Feb 6, 2015

    Feb 9, 2015 - Pdf

    Preview Download Resource
  • BSH 54th Annual Scientific Meeting, 2014 – CAT: current & future thinking

    BSH 54th Annual Scientific Meeting, 2014 – CAT: current & future thinking

    Feb 9, 2015 - Pdf

    Preview Download Resource
  • Clinical Audit Tool for NICE clinical guideline 114

    Clinical Audit Tool for NICE clinical guideline 114

    Feb 1, 2015 - Pdf

    Preview Download Resource
  • ACCP Practice Guideline Update 2016

    Feb 15, 2016

    Antithrombotic Therapy for VTE Disease. This document updates recommendations on 12 topics that were in the 9th edition of these guidelines, and addresses 3 new topics.

    ACCP Practice Guideline Update 2016
  • British Society of Haematology (BSH) Guideline on aspects of cancer-related venous thrombosis

    May 1, 2015

    The objective of this guideline is to provide healthcare professionals with clear guidance on the prevention and management of venous thromboembolism (VTE) in patients with cancer and to advise on an approach to screening for cancer in patients with unprovoked VTE in whom cancer was not initially suspected based on clinical grounds.

    British Society of Haematology (BSH) Guideline on aspects of cancer-related venous thrombosis
  • ASCO Practice Guideline Update 2014

    Jan 15, 2015

    The goal of this 2014 guideline update is to provide oncologists and other clinicians with current recommendations regarding the prevention and treatment of venous thromboembolism (VTE) in patients with cancer. The American Society of Clinical Oncology (ASCO) first published an evidence-based clinical practice guideline on VTE in patients with cancer in 2007, with an updated guideline published in 2013.

    ASCO Practice Guideline Update 2014
  • NICE VTE in Cancer Guidelines

    Jan 5, 2015

    This quality statement is taken from the diagnosis and management of venous thromboembolic diseases quality standard. The quality standard defines clinical best practice in diagnosing and managing venous thromboembolic diseases in adults and should be read in full.

    NICE VTE in Cancer Guidelines
  • ESMO Clinical Practice Guidelines

    Sep 1, 2011

    ESMO guideline for management of venous thromboembolism (VTE) in cancer patients covers clinical risk factors, diagnosis in occult malignancy, prevention of VTE, acute and long-term treatment in solid tumours, and anticoagulant therapy in patients with recurrent VTE.

    ESMO Clinical Practice Guidelines
  • ACCP Clinical Practice Guidelines

    Sep 1, 2004

    This article about unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH) is part of the Seventh American College of Chest Physicians Conference on Antithrombotic and Thrombolytic Therapy: Evidence-Based Guidelines.

    ACCP Clinical Practice Guidelines
x

You are now leaving the CAThrombosis.com site. This link goes to a site where our Terms of Use does not apply. You are solely responsible for the interaction with this site.

unknown
Cathrombosis.com

This website is provided as an educational service for Healthcare Professionals in the UK and Ireland only. Please check one of the boxes below to confirm your status:

YES. I am a Healthcare Professional NO. I am not a Healthcare Professional
Cathrombosis.com

This website is intended to provide non-promotional, educational information to an international healthcare professional audience only.

You have indicated that you are not a healthcare professional and therefore, do not have access to this site.

Please click here to continue browsing
This website uses cookies to give you the best experience online and to provide anonymised, aggregated site usage data. You can find out what cookies we use, what they do and how you can disable them in our COOKIE POLICY. By browsing this website and closing this message, you consent to our use of cookies on this device in accordance with our cookie policy unless you have disabled them.
Close
x
Cookie Policy

For the purpose of this Cookie Policy, our”, “us” or “we” means LEO Laboratories Limited (a company registered in the United Kingdom under number 662129) known as LEO Pharma (“LEO Pharma”), including LEO Pharma A/S, 2750 Ballerup, Denmark, CVR No. 56759514, LEO Laboratories Limited, Dublin, Ireland,  Reg. No. 16885 and any other LEO Pharma group company.

This website is owned by LEO Pharma.

When you use our website you accept that we use cookies as described below, unless you have altered the settings of your browser to not accept cookies.

For what purposes do we use cookies?

We use cookies on our website and any sub-domain to create the most secure and effective website possible for our visitors. Cookies may be used to help speed up your future activities and experience on our website. We also use cookies to compile anonymous, aggregated statistics that allow us to understand how people use our site and to help us improve the structure and content.

This Cookie Policy explains what cookies are, how we use them and what benefits they bring as well as how you can delete cookies.

What are cookies and what types of cookies do we use?

A cookie is a small text file that is sent to and stored on your computer, smartphone or other device for accessing the internet, whenever you visit a website. Cookies are useful because they allow a website to recognize a user's device and remember specific information about your session while you are connected. We use cookies on www.cathrombosis.com for a variety of reasons, such as to determine preferences, let users navigate between pages efficiently, verify the user and carry out other essential security checks.

Cookies by themselves cannot be used to discover the identity of the user, and they do not in any way damage your computer.

 

We use a Google Analytics cookie, further information can be seen here:: Google Analytics Cookie Usage

How do you avoid and delete cookies?

The browsers of most computers, smartphones and other web-enabled devices are typically set up to accept cookies. If you wish to amend your cookie preferences for this site or any other websites, you can do this through your browser settings. Your browser's 'help' function will tell you how to do this.

However, please remember that cookies are often used to enable and improve certain functions on our site. If you therefore choose to disable the cookies that we use, this may impact your experience while on www.cathrombosis.com, for example, you may not be able to visit certain areas of the site and you may not receive personalised information.

If you use different devices to view and access the site (e.g. your computer, smartphone, tablet etc.) you will need to ensure that each browser on each device is adjusted to suit your cookie preferences.

For more information on how to disable cookies, visit www.allaboutcookies.org